形成外科の世界市場（2024年～2031年）

世界の形成外科の市場規模は、2023年に697億米ドルに達し、2031年には1,587億米ドルに達すると予測され、予測期間2024年～2031年にはCAGR11.1％で成長する見込みです。

形成外科は、病気、外傷、生まれつきの障害による顔や体の組織欠損の再建と外見の改善に関わる外科的専門分野です。形成外科は、外見だけでなく、機能の回復と改善を行います。中枢神経系を除く、解剖学上のあらゆる部位の手術が含まれます。形成外科として知られる外科の専門分野は、人体の再建、拡張、変化を扱います。美容外科と再建外科は、形成外科の2つのサブカテゴリーです。

さらに、高齢者人口の増加、低侵襲手術の採用、手術コストの削減、市場における認定サービス提供者の増加、新製品発売数の増加により、これらの整形手術に対する消費者の需要が高まっていることが、形成外科の市場規模を押し上げています。同市場では、北米地域の研究開発の結果、製品に対する需要が伸びています。Allergan Aesthetics（AbbVie Inc.）、Merz Aesthetics、Cynosure LLCなど、その他の競合企業も積極的に活動しています。

市場力学：

促進要因と抑制要因

形成外科施術に対する需要の増加

形成外科施術に対する需要の増加は、世界の形成外科市場の成長において重要な要因となることが予想されます。高齢者人口の増加、傷跡や怪我の増加、技術の進歩、最近の発売、承認などの要因が形成外科施術の需要を増加させています。高齢者人口の増加は、世界の形成外科市場に大きな影響を与えると予想されます。平均寿命が延び、高齢者人口が増加するにつれて、しわ、皮膚のたるみ、体積減少などの加齢に関連する問題に対処する美容治療に対するニーズが高まっています。フェイスリフト、皮膚充填剤、ボトックス注射は、外見を改善する方法として高齢者の間で人気が高まっています。

交通事故や火傷の増加により、瘢痕治療を必要とする患者の数が増加しており、瘢痕修正や美的改善を目的とした様々な形成外科手術の需要を押し上げています。例えば、世界保健機関（WHO）によると、毎年推定18万人が火傷により死亡しています。その大部分は中低所得国で発生しています。インドでは、毎年100万人以上が中等度または重度の火傷を負っています。

美化や外見向上の必要性から、施術件数は日々増加しています。例えば、米国形成外科学会によると、米国では2023年に、合計30万4,181件の豊胸手術、34万7,782件の脂肪吸引手術、12万747件のまぶたの手術・処置が行われました。

高齢者人口の増加が予測期間における市場成長の主な促進要因です。世界中で高齢者人口が増加しているため、形成外科に対する需要も増加しています。例えば、国連の発表によると、2023年には世界の60歳以上の人口は10億6,000万人に達し、2030年には同年齢層の人口は13億3,000万人に増加すると予測されています。増加する高齢者人口のため、形成外科と治療の最近の発売があります。例えば、2024年9月、アッヴィ傘下のアラガン・エステティックは、咬筋優位（MMP）の治療薬としてBOTOX Cosmetic（オナボツリヌムトキシンA）が中国で発売されたと発表しました。咬筋は下顔面の咀嚼筋の一つで、咬筋優位になると下顔面が広く四角くなります。中国国家医療品監督管理局（NMPA）は最近、成人における著しい～極めて著しいMMPの見た目を一時的に改善するBOTOX Cosmeticを承認しました。BOTOX Cosmeticは、MMPに対して中国で承認された最初の神経毒であり、定められた用量、強力な臨床データ、適応外治療に伴う医師のトレーニングが含まれています。

形成外科に関連する副作用

形成外科に関連する副作用などの要因は、世界の形成外科市場の妨げになると予想されます。感染症、大出血、瘢痕化、麻酔やインプラントに関連した副作用はすべて一般的な問題です。これらの危険は患者の安全を脅かすだけでなく、結果に対する不満につながり、施術者の法的責任や専門家としての評判を傷つけることにもなりかねません。例えば、米国国立衛生研究所によると、肉芽腫の持続や感染症などの長期的な有害事象が報告されています。これらは、無菌処置の緩みやバイオフィルムの形成が原因である可能性があります。フィラーによる有害事象は、持続するだけでなく、永久的な失明などの深刻な合併症につながる可能性もあります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 高齢者人口の増加
  • 抑制要因
    • 美容レーザーに伴う副作用
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 手術タイプ別

• 再建手術
• 美容外科手術
• 美容（低侵襲）処置

第7章 ジェンダー別

• 女性
• 男性

第8章 年齢層別

• 13～19歳
• 20～29歳
• 30～39歳
• 40～54歳
• 55～69歳
• 70歳以上

第9章 エンドユーザー別

• 病院
• 外科センター/クリニック
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Allergan Aesthetics（AbbVie Inc.）
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Alma Lasers
• Cynosure LLC
• Galderma
• Bausch Health Companies Inc.
• Merz Aesthetics
• Candela Corporation
• Evolus, Inc.
• Lumenis Be Ltd.
• GC Aesthetics.

第13章 付録

The global plastic surgery market reached US$ 69.7 billion in 2023 and is expected to reach US$ 158.7 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031.

Plastic surgery is a surgical specialty involved with both the improvement of a person's appearance and the reconstruction of facial and body tissue defects due to illness, trauma, or birth disorders. Plastic surgery restores and improves function, as well as appearance. It can involve surgery on any part of the anatomy, except the central nervous system. A surgical specialty known as plastic surgery deals with the reconstruction, augmentation, or change of the human body. Cosmetic surgery and reconstructive surgery are the two subcategories of plastic surgery.

Moreover, rising consumer demand for these plastic procedures due to the increasing geriatric population, adoption of minimally invasive procedures, reduced procedural costs, an increase in the number of authorized service providers in the market, and an increase in the number of new product launches are driving up the plastic surgery market size. The market is experiencing a growth in demand for products from North American areas as a result of the development of research in these fields. Significant competitors like Allergan Aesthetics (AbbVie Inc.), Merz Aesthetics, Cynosure LLC, and others actively operating in the ma rket.

Market Dynamics: Drivers & Restraints

Increasing demand for plastic surgery procedures

The increasing demand for plastic surgery procedures is expected to be a significant factor in the growth of the global plastic surgery market. Factors such as the increasing geriatric population, increase in the number of scars and injuries, technological advancements, recent launches, and approvals increase the demand for plastic surgery procedures. The growing geriatric population is expected to have a substantial impact on the global plastic surgery market. As life expectancy increases and the older population grows, there is a greater need for aesthetic treatments that address age-related issues such as wrinkles, sagging skin, and volume loss. Facelifts, dermal fillers, and Botox injections are becoming increasingly popular among elderly individuals as a way to improve their appearance.

The rising occurrence of traffic accidents and burn injuries has resulted in a greater number of patients requiring scar therapy, driving up demand for various plastic surgery operations aimed at scar revision and aesthetic improvement. For instance, according to the World Health Organization, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year.

The number of procedures performed is increasing day by day due to the need for beautification and to improve appearance. For instance, according to the American Society of Plastic Surgeons, in 2023, in the US, a total of 304,181 Breast augmentation procedures, 347,782 liposuction procedures, and 120,747 eyelid surgeries and procedures were performed.

The increasing geriatric population is the major driver for market growth in the forecast period. As the geriatric population across the globe is rising, the demand for plastic surgery is increasing. For instance, as per the United Nations, in 2023, the global population above 60 years of age accounted for 1.06 billion, and the same age group population is expected to rise to 1.33 billion in 2030. For the increasing geriatric population, there are recent launches for plastic surgery and treatment. For instance, in September 2024, Allergan Aesthetics, an AbbVie company announced that BOTOX Cosmetic (onabotulinumtoxinA) is now available in China to treat masseter muscle predominance (MMP). The masseter muscle is one of the lower face's chewing muscles, and its predominance can result in a wide and square lower face shape1. The China National Medical Product Administration (NMPA) recently approved BOTOX Cosmetic to temporarily enhance the appearance of significant to extremely marked MMP in adults. BOTOX Cosmetic is the first neurotoxin approved in China for MMP, and it includes the defined dose, strong clinical data, and physician training associated with on-label treatment.

Side effects associated with plastic surgery

Factors such as side effects associated with plastic surgery are expected to hamper the global plastic surgery market. Infections, severe bleeding, scarring, and anesthetic or implant-related adverse responses are all common problems. These dangers not only endanger patient safety, but they can also lead to dissatisfaction with results, resulting in legal liability for practitioners and harming their professional reputations. For instance, according to the National Institute of Health, long-term adverse events such as persistent granulomas and infections are being reported. These may be due to laxity in aseptic procedures or the formation of biofilms. Adverse events with fillers can not only be persistent but can also lead to serious complications such as permanent blindness.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type gender, age group, end-user, and region.

The cosmetic (minimally-invasive) procedures segment is expected to dominate the global plastic surgery market share

The segment of minimally invasive cosmetic operations is expected to dominate the global plastic surgery market as a result of technical improvements, patient preferences, recent launches with technological advancements, and the inherent benefits of these procedures. Minimally invasive therapies, such as Botox injections, dermal fillers, and laser treatments, have grown in favor since they often require minimal incisions or none at all. This strategy lessens the physical damage associated with standard operations, as well as scars and recovery time, making these solutions more appealing to a broader audience.

Due to increasing demand for minimally invasive procedures, there are so many new launches, especially in the lasers section. For instance, in September 2023, Cutera, Inc. a global leader in aesthetic and dermatology solutions, announced the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. It is Optimized to treat varying layers of the skin; the Secret DUO is equipped with a radio frequency microneedling (RFMN) handpiece along with a fractional non-ablative 1540 nm erbium glass laser. The unique pairing of these modalities allows practitioners to provide fully customizable solutions for fine lines, texture, pigment, stretch marks, and scars.

Geographical Analysis

North America is expected to hold a significant position in the global plastic surgery market share

North America is expected to hold a significant portion of the global plastic surgery market. North America is anticipated to play a leading position in the global plastic surgery market owing to various factors such as the increasing geriatric population, technological advancements, recent launches and approvals, and the presence of strong players in this region. In this region, there is an increasing geriatric population which leads growth of the market in this region due to skin issues faced by the geriatric population. For instance, according to the Pew Research Center, the number of Americans ages 100 and older is projected to more than quadruple over the next three decades, from an estimated 101,000 in 2024 to about 422,000 in 2054, according to projections from the U.S. Census Bureau.

Due to the presence of the major players, there are recent launches and approvals in this region which makes this region hold a significant position in the global plastic surgery market. For instance, in January 2023, Reveal Lasers LLC announced the launch of the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The device's intuitive user interface has color-coded screens based on the active wavelength, allowing professionals to customize treatments for each patient. The strategic partnerships in this region are also one of the main reasons for the market to prosper in this region. For instance, in January 2024, United Aesthetics Alliance established to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, announced that it has formed a new partnership with the Bengtson Center for Aesthetics & Plastic Surgery. BCAPS, headquartered in Grand Rapids, MI, is a leading plastic surgery and aesthetics provider in West Michigan and it is led by two recognized board-certified plastic surgeons.

Asia Pacific is growing at the fastest pace in the global plastic surgery market

The Asia Pacific region is witnessing rapid expansion in the plastic surgery market, propelled by economic advancement, an increasing geriatric population, and technological advancements. This expansion is especially evident in nations such as Korea, Japan, and India, where investments in dermatology, skincare, and wellness, and awareness about plastic surgery procedures have been increasing day by day during recent times. There are recent approvals and launches in this region which propels the market. For instance, in May 2024, Korean startup MediThinQ announced the launch of its SCOPEYE 3D Micro Surgery Solution, which uses the latest Eyes Up Display technology for improving precision across medical specialties. The SCOPEYE 3D Micro Surgery Solution's portability and space-saving features make it suitable for a wide array of medical procedures, including microsurgery, dental procedures, plastic surgery, ophthalmology, hair transplant surgery, and dermatology.

Competitive Landscape

The major global players in the global plastic surgery market include Allergan Aesthetics (AbbVie Inc.), Alma Lasers, Cynosure LLC, Galderma, Bausch Health Companies Inc., Merz Aesthetics, Candela Corporation, Evolus, Inc., Lumenis Be Ltd., GC Aesthetics among others.

Emerging Players

MediThinQ, Avance Innovation, and ReConstruct Bio among others

Key Developments

• In May 2023, the U.S. FDA approved SKINVIVE by JUVEDERM for enhancing the skin softness of the cheeks in individuals over the age of 21, according to a statement from Allergan Aesthetics, a division of AbbVie. The sole and first intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness to be made available in the United States is called SKINVIVE by JUVEDERM. With proper care, benefits can last up to six months. Smooth, injectable HA gel called SKINVIVE by JUVEDERM includes a trace dose of lidocaine, a local anesthetic.
• In June 2023, Restylane Eyelight was approved by the U.S. Food and Drug Administration (FDA) for the treatment of dark shadows under the eyes in individuals over the age of 21. The first and sole product in the United States designed using NASHA Technology addressing volume loss beneath the eyes, Restylane Eyelight is a dermal filler made of hyaluronic acid (HA) that gives patients results that seem natural.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global plastic surgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Surgical Procedure Type
• 3.2. Snippet by Gender
• 3.3. Snippet by Age Group
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Geriatric Population
  • 4.1.2. Restraints
    • 4.1.2.1. Side Effects Associated with Aesthetic Lasers
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Surgical Procedure Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 6.1.2. Market Attractiveness Index, By Surgical Procedure Type
• 6.2. Reconstructive Surgical Procedure*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Cosmetic (aesthetic) Surgical Procedure
• 6.4. Cosmetic (Minimally-Invasive) Procedures

7. By Gender

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 7.1.2. Market Attractiveness Index, By Gender
• 7.2. Female*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Male

8. By Age Group

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 8.1.2. Market Attractiveness Index, By Age Group
• 8.2. 13-19 yrs*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. 20-29 yrs
• 8.4. 30-39 yrs
• 8.5. 40-54 yrs
• 8.6. 55-69 yrs
• 8.7. 70+ yrs

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Surgical Centers/ Clinics
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Allergan Aesthetics (AbbVie Inc.)*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Alma Lasers
• 12.3. Cynosure LLC
• 12.4. Galderma
• 12.5. Bausch Health Companies Inc.
• 12.6. Merz Aesthetics
• 12.7. Candela Corporation
• 12.8. Evolus, Inc.
• 12.9. Lumenis Be Ltd.
• 12.10. GC Aesthetics.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us